Doximity, Inc. (NASDAQ:DOCS – Get Free Report) has received a consensus rating of “Hold” from the twenty ratings firms that are currently covering the firm, MarketBeat reports. Thirteen investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $52.59.
Several research analysts recently issued reports on DOCS shares. Canaccord Genuity Group lowered Doximity from a “buy” rating to a “hold” rating and raised their target price for the stock from $40.00 to $60.00 in a research report on Wednesday, November 13th. Evercore ISI raised their price objective on Doximity from $34.00 to $45.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. Raymond James reaffirmed an “outperform” rating and issued a $65.00 price objective (up from $37.00) on shares of Doximity in a research note on Friday, November 8th. Canaccord Genuity Group reissued a “hold” rating and set a $60.00 target price (up previously from $40.00) on shares of Doximity in a research report on Wednesday, November 13th. Finally, Morgan Stanley upgraded shares of Doximity from an “underweight” rating to an “equal weight” rating and boosted their price target for the stock from $33.00 to $53.00 in a research report on Thursday, November 14th.
Get Our Latest Report on Doximity
Institutional Investors Weigh In On Doximity
Doximity Stock Performance
Shares of NASDAQ DOCS opened at $53.56 on Friday. The stock has a market cap of $10.00 billion, a P/E ratio of 61.56, a price-to-earnings-growth ratio of 4.16 and a beta of 1.40. The firm has a 50 day moving average price of $51.29 and a two-hundred day moving average price of $40.37. Doximity has a 52-week low of $22.96 and a 52-week high of $61.75.
About Doximity
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Recommended Stories
- Five stocks we like better than Doximity
- How to Calculate Return on Investment (ROI)
- 3 Legacy Tech Companies Reemerging as AI LeadersÂ
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.